Overview

rTMS for Apathy Clinical Trial

Status:
Recruiting
Trial end date:
2024-09-01
Target enrollment:
Participant gender:
Summary
Apathy is a common, early, and disabling symptom in dementias such as Alzheimer's disease (AD) and is characterized by lack of interest and enthusiasm. Both repetitive transcranial magnetic stimulation (rTMS), a form of non-invasive brain stimulation, and methylphenidate, a medication, have been shown to improve apathy. This pilot study will investigate rTMS as a treatment for apathy in AD in individuals receiving methylphenidate and individuals not receiving medication for apathy.
Phase:
N/A
Details
Lead Sponsor:
Sunnybrook Health Sciences Centre
Treatments:
Methylphenidate